Company · Toronto, Ontario, Canada
Purdue Pharma
Everything this company holds in Health Canada’s product databases, as the company’s name is spelled there.
- Drug products (DIN)
- 118
- 49 authorized now
- Natural health products
- 4
- 0 active licences
- Medical device licences
- 0
- 0 active
- Notices of Compliance
- 75
Drug products
Authorized products first.
| Name | DIN | Status | Status since |
|---|---|---|---|
| BUTRANS 10 | 02341212 | Marketed | |
| BUTRANS 15 | 02450771 | Marketed | |
| BUTRANS 20 | 02341220 | Marketed | |
| BUTRANS 5 | 02341174 | Marketed | |
| CODEINE CONTIN 100MG CONTROLLED RELEASE TAB | 02163748 | Marketed | |
| CODEINE CONTIN 150MG CONTROLLED RELEASE TAB | 02163780 | Marketed | |
| CODEINE CONTIN 200MG CONTROLLED RELEASE TAB | 02163799 | Marketed | |
| CODEINE CONTIN 50MG CONTROLLED RELEASE TAB | 02230302 | Marketed | |
| DILAUDID | 00125083 | Marketed | |
| DILAUDID | 00125121 | Marketed | |
| DILAUDID | 00705438 | Marketed | |
| DILAUDID | 00786543 | Marketed | |
| HYDROMORPH CONTIN | 02359502 | Marketed | |
| HYDROMORPH CONTIN | 02359510 | Marketed | |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 12MG | 02125366 | Marketed | |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 18MG | 02243562 | Marketed | |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 24MG | 02125382 | Marketed | |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 30MG | 02125390 | Marketed | |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 3MG | 02125323 | Marketed | |
| HYDROMORPH CONTIN-CONTROLLED RELEASE CAP - 6MG | 02125331 | Marketed | |
| MS CONTIN | 02014327 | Marketed | |
| MS CONTIN | 02014297 | Marketed | |
| MS CONTIN | 02014319 | Marketed | |
| MS CONTIN | 02014300 | Marketed | |
| MS CONTIN | 02015439 | Marketed | |
| MS.IR | 02014211 | Marketed | |
| MS.IR | 02014203 | Marketed | |
| MS.IR | 02014238 | Marketed | |
| MS.IR | 02014254 | Marketed | |
| OXY.IR | 02231934 | Marketed | |
| OXY.IR | 02240131 | Marketed | |
| OXY.IR | 02240132 | Marketed | |
| OXYNEO | 02372525 | Marketed | |
| OXYNEO | 02372533 | Marketed | |
| OXYNEO | 02372541 | Marketed | |
| OXYNEO | 02372568 | Marketed | |
| OXYNEO | 02372576 | Marketed | |
| OXYNEO | 02372584 | Marketed | |
| OXYNEO | 02372797 | Marketed | |
| TARGIN | 02339609 | Marketed | |
| TARGIN | 02339617 | Marketed | |
| TARGIN | 02339625 | Marketed | |
| TARGIN | 02387425 | Marketed | |
| ZYTRAM XL | 02286424 | Marketed | |
| ZYTRAM XL | 02286432 | Marketed | |
| ZYTRAM XL | 02286440 | Marketed | |
| ZYTRAM XL | 02286459 | Marketed | |
| ZYTRAM XL | 02360322 | Marketed | |
| ZYTRAM XL | 02360349 | Marketed | |
| BELBUCA | 02465221 | Cancelled Post Market | |
| BELBUCA | 02465248 | Cancelled Post Market | |
| BELBUCA | 02465256 | Cancelled Post Market | |
| BELBUCA | 02465264 | Cancelled Post Market | |
| BELBUCA | 02465272 | Cancelled Pre Market | |
| BELBUCA | 02465280 | Cancelled Pre Market | |
| BELBUCA | 02465299 | Cancelled Pre Market | |
| BETADINE AEROSOL SPRAY 5% | 00158305 | Cancelled Post Market | |
| BETADINE GAUZE PADS 10% | 00417416 | Cancelled Post Market | |
| BETADINE SHAMPOO 7.5% | 00158321 | Cancelled Post Market | |
| BETADINE SHAMPOO FOR DRY HAIR 4% | 00251704 | Cancelled Post Market | |
| BETADINE SKIN CLEANSER 7.5% | 00230065 | Cancelled Post Market | |
| BETADINE SOLUTION SWAB AID 10% | 00276731 | Cancelled Post Market | |
| BETADINE VAGINAL DOUCHE 10% | 00026093 | Cancelled Post Market | |
| BETADINE VAGINAL GEL 10% | 00026034 | Cancelled Post Market | |
| BETADINE VAGINAL SUPPOSITORIES 200MG | 00026050 | Cancelled Post Market | |
| CARDIOQUIN TABLETS | 00026131 | Cancelled Post Market | |
| CERUMENEX | 00158356 | Cancelled Post Market | |
| DILAUDID | 00627100 | Cancelled Post Market | |
| DILAUDID | 00125105 | Cancelled Post Market | |
| DILAUDID | 00786535 | Cancelled Post Market | |
| DILAUDID | 02085895 | Cancelled Post Market | |
| DILAUDID HP | 00622133 | Cancelled Post Market | |
| DILAUDID-HP-PLUS | 02146118 | Cancelled Post Market | |
| DILAUDID-XP | 02145863 | Cancelled Post Market | |
| ENTEX LA | 02231572 | Cancelled Post Market | |
| ENTEX LA | 02246971 | Cancelled Post Market | |
| GENTLAX | 02248282 | Cancelled Post Market | |
| GENTLAX S | 02252872 | Cancelled Post Market | |
| HYDROMORPH.IR - 2MG | 02245703 | Cancelled Post Market | |
| HYDROMORPH.IR - 4MG | 02245704 | Cancelled Post Market | |
| HYDROMORPH.IR - 8MG | 02245705 | Cancelled Post Market | |
| MS CONTIN SUPPOSITORIES - 100MG | 02145952 | Cancelled Post Market | |
| MS CONTIN SUPPOSITORIES - 200MG | 02145960 | Cancelled Post Market | |
| MS CONTIN SUPPOSITORIES - 30MG | 02146827 | Cancelled Post Market | |
| MS CONTIN SUPPOSITORIES - 60MG | 02145944 | Cancelled Post Market | |
| MS CONTIN TABLETS | 02229420 | Cancelled Pre Market | |
| MS CONTIN XL CAPSULES | 02242827 | Cancelled Pre Market | |
| MS CONTIN XL CAPSULES | 02242828 | Cancelled Pre Market | |
| MS CONTIN XL CAPSULES | 02242829 | Cancelled Pre Market | |
| MS CONTIN XL CAPSULES | 02242830 | Cancelled Pre Market | |
| MS CONTIN XL CAPSULES | 02242831 | Cancelled Pre Market | |
| MS CONTIN XL CAPSULES | 02242832 | Cancelled Pre Market | |
| MS IR SUP 10MG | 02014246 | Cancelled Post Market | |
| MS IR SUP 20MG | 02014262 | Cancelled Post Market | |
| MS IR SUP 30MG | 02014173 | Cancelled Post Market | |
| OXYCONTIN | 02323192 | Cancelled Post Market | |
| OXYCONTIN | 02323206 | Cancelled Post Market | |
| OXYCONTIN | 02323214 | Cancelled Post Market | |
| OXYCONTIN 10MG | 02202441 | Cancelled Post Market | |
| OXYCONTIN 20MG | 02202468 | Cancelled Post Market | |
| OXYCONTIN 40MG | 02202476 | Cancelled Post Market | |
| OXYCONTIN 5MG | 02258129 | Cancelled Post Market | |
| OXYCONTIN 80MG | 02202484 | Cancelled Post Market | |
| PALLADONE XL - 12MG | 02243159 | Cancelled Post Market | |
| PALLADONE XL - 16MG | 02243160 | Cancelled Post Market | |
| PALLADONE XL - 24MG | 02243161 | Cancelled Post Market | |
| PHYLLOCONTIN | 02014270 | Cancelled Post Market | |
| PHYLLOCONTIN-350 | 02014289 | Cancelled Post Market | |
| SAFLUTAN | 02425149 | Cancelled Pre Market | |
| SENOKOT GRANULES | 00026042 | Cancelled Post Market | |
| SENOKOT SUPP | 00026107 | Cancelled Post Market | |
| TEEJEL GEL | 00026190 | Cancelled Post Market | |
| TIMOPTIC-XE | 02171880 | Cancelled Post Market | |
| TRILISATE TAB | 00449636 | Cancelled Post Market | |
| UROMAX | 02273578 | Cancelled Post Market | |
| UROMAX | 02273586 | Cancelled Post Market | |
| X PREP LIQ | 00367737 | Cancelled Post Market | |
| X PREP POWDER 3.5GM | 00026069 | Cancelled Post Market |
Natural health products
Active licences first, newest first.
| Name | NPN | Status | Licensed |
|---|---|---|---|
| Kiwi Balance | 80093082 | Discontinued | |
| Betadine Antiseptic Cream | 80083175 | Discontinued | |
| Senokot Ginger Relief | 80079080 | Discontinued | |
| Senokot Syrup | 00367729 | Discontinued |
Notices of Compliance
Newest first.
- CODEINE CONTINJuly 15, 2026 · NOC 37932 · Supplement to a New Drug Submission (SNDS)
- ZYTRAM XLNovember 19, 2025 · NOC 36403 · Supplement to a New Drug Submission (SNDS)
- BUTRANSNovember 14, 2025 · NOC 36384 · Supplement to a New Drug Submission (SNDS)
- CODEINE CONTINMarch 4, 2025 · NOC 34983 · Supplement to a New Drug Submission (SNDS)
- OXYNEOFebruary 27, 2025 · NOC 34918 · Supplement to a New Drug Submission (SNDS)
- OXY.IRFebruary 27, 2025 · NOC 34919 · Supplement to a New Drug Submission (SNDS)
- MS CONTINAugust 27, 2024 · NOC 33875 · Supplement to a New Drug Submission (SNDS)
- ZYTRAM XLDecember 5, 2023 · NOC 32276 · Supplement to a New Drug Submission (SNDS)
- OXYNEODecember 1, 2023 · NOC 32245 · Supplement to a New Drug Submission (SNDS)
- OXY.IRNovember 28, 2023 · NOC 32189 · Supplement to a New Drug Submission (SNDS)
- TARGINOctober 19, 2023 · NOC 31902 · Supplement to a New Drug Submission (SNDS)
- DILAUDIDAugust 30, 2023 · NOC 31525 · Supplement to a New Drug Submission (SNDS)
- HYDROMORPH CONTINAugust 28, 2023 · NOC 31501 · Supplement to a New Drug Submission (SNDS)
- MS CONTINAugust 15, 2023 · NOC 31429 · Supplement to a New Drug Submission (SNDS)
- BUTRANSJuly 24, 2023 · NOC 31286 · Supplement to a New Drug Submission (SNDS)
- ZYTRAM XLMay 18, 2023 · NOC 30791 · Supplement to a New Drug Submission (SNDS)
- OXY.IROctober 31, 2022 · NOC 29344 · Supplement to a New Drug Submission (SNDS)
- OXYNEOJuly 14, 2022 · NOC 28585 · Supplement to a New Drug Submission (SNDS)
- MS CONTINJuly 4, 2022 · NOC 28509 · Supplement to a New Drug Submission (SNDS)
- ZYTRAM XLMarch 31, 2022 · NOC 27865 · Supplement to a New Drug Submission (SNDS)
- FOQUESTJuly 31, 2020 · NOC 23980 · Supplement to a New Drug Submission (SNDS)
- FOQUESTMay 22, 2020 · NOC 23654 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINMay 20, 2020 · NOC 23637 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINJanuary 15, 2020 · NOC 23112 · Supplement to a New Drug Submission (SNDS)
- ZYTRAM XLDecember 13, 2019 · NOC 23016 · Supplement to a New Drug Submission (SNDS)
- ALOXIJune 4, 2019 · NOC 22234 · Supplement to a New Drug Submission (SNDS)
- ALOXIApril 8, 2019 · NOC 22046 · Supplement to a New Drug Submission (SNDS)
- FOQUESTMarch 5, 2019 · NOC 21923 · Supplement to a New Drug Submission (SNDS)
- PENTHROXDecember 14, 2018 · NOC 21634 · Supplement to a New Drug Submission (SNDS)
- PENTHROXApril 7, 2018 · NOC 20719 · New Drug Submission (NDS)
- TARGINJanuary 23, 2018 · NOC 20392 · Supplement to a New Drug Submission (SNDS)
- FOQUESTDecember 6, 2017 · NOC 20242 · New Drug Submission (NDS)
- AKYNZEOSeptember 28, 2017 · NOC 19860 · New Drug Submission (NDS)
- BELBUCASeptember 7, 2017 · NOC 19768 · New Drug Submission (NDS)
- ALOXIMay 29, 2017 · NOC 19361 · New Drug Submission (NDS)
- OXYNEOMay 11, 2017 · NOC 19289 · Supplement to a New Drug Submission (SNDS)
- SAFLUTANNovember 3, 2016 · NOC 18628 · New Drug Submission (NDS)
- TRUSOPT; TRUSOPT (PRESERVATIVE-FREE FORMULATION)November 2, 2016 · NOC 18621 · New Drug Submission (NDS)
- TIMOPTIC; TIMOPTIC-XEOctober 28, 2016 · NOC 18658 · New Drug Submission (NDS)
- COSOPT; COSOPT (PRESERVATIVE-FREE)October 25, 2016 · NOC 18605 · New Drug Submission (NDS)
- TARGINMarch 3, 2016 · NOC 17830 · Supplement to a New Drug Submission (SNDS)
- BUTRANSJanuary 12, 2016 · NOC 17664 · Supplement to a New Drug Submission (SNDS)
- OXYNEOMarch 14, 2014 · NOC 15408 · Supplement to a New Drug Submission (SNDS)
- OXYNEOAugust 8, 2013 · NOC 14633 · Supplement to a New Drug Submission (SNDS)
- TARGINJuly 26, 2013 · NOC 14607 · Supplement to a New Drug Submission (SNDS)
- TARGINJune 6, 2012 · NOC 13360 · Supplement to a New Drug Submission (SNDS)
- OXYNEOAugust 22, 2011 · NOC 12583 · New Drug Submission (NDS)
- ZYTRAM XLDecember 2, 2010 · NOC 11895 · Supplement to a New Drug Submission (SNDS)
- HYDROMORPH CONTINNovember 17, 2010 · NOC 11873 · Supplement to a New Drug Submission (SNDS)
- UROMAXJune 18, 2010 · NOC 11540 · Supplement to a New Drug Submission (SNDS)
- BUTRANSMarch 5, 2010 · NOC 11114 · New Drug Submission (NDS)
- TARGINDecember 16, 2009 · NOC 10866 · New Drug Submission (NDS)
- HYDROMORPH CONTINAugust 27, 2009 · NOC 10548 · Supplement to a New Drug Submission (SNDS)
- OXY.IRAugust 27, 2009 · NOC 10549 · Supplement to a New Drug Submission (SNDS)
- HYDROMORPH.IRAugust 27, 2009 · NOC 10550 · Supplement to a New Drug Submission (SNDS)
- OXYCONTINAugust 27, 2009 · NOC 10551 · Supplement to a New Drug Submission (SNDS)
- MS CONTINAugust 27, 2009 · NOC 10552 · Supplement to a New Drug Submission (SNDS)
- CODEINE CONTINAugust 27, 2009 · NOC 10553 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINJune 22, 2009 · NOC 10268 · Supplement to a New Drug Submission (SNDS)
- OXYCONTINMarch 4, 2009 · NOC 10073 · Supplement to a New Drug Submission (SNDS)
- DILAUDIDAugust 8, 2008 · NOC 9710 · New Drug Submission (NDS)
- DILAUDID; DILAUDID-HP; DILAUDID-HP PLUS; DILAUDID-XPAugust 8, 2008 · NOC 9711 · New Drug Submission (NDS)
- ZYTRAM XLJuly 2, 2008 · NOC 9658 · Supplement to a New Drug Submission (SNDS)
- ZYTRAM XLSeptember 28, 2006 · NOC 8283 · New Drug Submission (NDS)
- UROMAXAugust 2, 2006 · NOC 8190 · Supplement to a New Drug Submission (SNDS)
- BIPHENTINMarch 28, 2006 · NOC 7843 · New Drug Submission (NDS)
- UROMAXDecember 1, 2005 · NOC 7637 · New Drug Submission (NDS)
- HYDROMORPH.IRDecember 24, 2004 · NOC 6011 · Supplement to a New Drug Submission (SNDS)
- OXYCONTINSeptember 23, 2004 · NOC 5406 · Supplement to a New Drug Submission (SNDS)
- OXYCONTINSeptember 25, 2003 · NOC 3422 · Supplement to a New Drug Submission (SNDS)
- OXYCONTINDecember 16, 2002 · NOC 727 · Supplement to a New Drug Submission (SNDS)
- PALLADONE IRMay 30, 2002 · NOC 580 · Supplement to a New Drug Submission (SNDS)
- HYDROMORPH CONTINMarch 29, 2001 · NOC 2315 · Supplement to a New Drug Submission (SNDS)
- PALLADONE XLDecember 19, 2000 · NOC 1200 · New Drug Submission (NDS)
- MS CONTIN XL CAPSULESSeptember 14, 2000 · NOC 1293 · Supplement to a New Drug Submission (SNDS)
Recalls and safety alerts that mention its products
Health Canada’s recall notices do not carry licence numbers, so these are matched by name. A notice may cover another product or only some lots: read it to see what it covers.
- Hydromorph Contin - Controlled Release Capsule 24 mg (2019-04-12)April 12, 2019 · Drugs · Product safety · Type II